Skip to content
DraconiticResearch
Search Sources API
210,049 studies31 sourcesUpdated 13 min ago

Oncology

5,302 studies557 in 7 days2,546 in 30 days

Filters
Type
Date
Clear

Latest

5,302 studies

  1. Lymphocyte to C-reactive protein ratio and improved prognostication of renal cell carcinoma: machine learning-based analysis
    Melis Guer, Cesare Saitta, Viraj Master +19
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefPMC
  2. Predictors of guideline-concordant treatment intensification in metastatic castration-sensitive prostate cancer: an explainable machine learning study
    Emmanuel Barton Odro, James Bychinski, Ted Van Alstyne +9
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefPMC
  3. Case Report: Clinicopathologic and molecular characteristics of prostate adenocarcinoma brain metastases despite disproportionately low PSA levels: a four-patient case series and narrative review
    Roshmita Bardhan, Zin W. Myint, Harit Kapoor +1
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefPMC
  4. Salvage nivolumab plus temozolomide associated with improved survival and clinical benefit in refractory melanoma: a retrospective cohort study
    Preethy E. Abraham, Kun Bai, Sheau-Chiann Chen +1
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefPMC
  5. Unveiling the heterogeneity: PD-L1 expression and metabolic activity in primary vs. metastatic NSCLC, a retrospective single-center analysis
    Bingxin Hu, Huibin Jin, Yue Yu +6
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefPMC
  6. CNIH4 as a prognostic biomarker and promoter of malignant progression in head and neck squamous cell carcinoma
    Jun Chen, Aitao Nai, Jijie Cai +3
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefPMC
  7. Tislelizumab-induced immune-mediated hepatotoxicity combined with two episodes of hepatitis B virus reactivation: a case report
    Dongxuan Li, Guiqin Peng
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefPMC
  8. Therapeutic Lymphaticovenular Anastomosis for Breast Cancer-Related Lymphedema: A Critical Narrative Review of Comparative Evidence
    Stiven Yusufov, Evgeniia Iliina, Maria Ermoshchenkova +2
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0OncologyCrossref
  9. Cohort profile: KaroLiver, a population-based cohort of patients receiving curative liver-directed treatment for colorectal liver metastases at a Swedish tertiary centre
    Marco Gerling, Carlos Fernández Moro, Celina Limbecker +13
    BMJ OpenPeer-reviewedCC BY 4.0Full textOncologyCrossref
  10. Association between physical activity and quality of life among breast cancer survivors in China: a cross-sectional mediation analysis
    Yingjie Yao, Qinqin Cheng, Andy S K Cheng +4
    BMJ OpenPeer-reviewedCC BY-NC 4.0Full textOncologyCrossref
  11. Safety of concurrent immune checkpoint inhibitor therapy during postoperative radiotherapy for triple-negative breast cancer: A preliminary retrospective analysis
    Gai Liang, Qu Zhang, Mengting Yuan +2
    Oncology LettersPeer-reviewedLicence not statedFull textOncologyPMC
  12. Unveiling a dual-pathway prognostic model: Integrating T cell-related and ubiquitination-related genes in lung adenocarcinoma
    Shuang Zeng, Huidi Gao, Hongying Liang +1
    Oncology LettersPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMCEurope PMC
  13. The double-edged sword of TOX: orchestrating T cell exhaustion and epigenetic remodeling in the tumor microenvironment
    Gaia Zuccolotto, Lodovica Borghese, Alessia Rebuli +2
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  14. Editorial: Community series in unveiling the next generation of cancer immunity & immunotherapy in lung cancer, volume II
    Nethaji Muniraj, Mohanraj Sadasivam, Chellappagounder Thangavel
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  15. Editorial: Beyond conventional biomarkers: unlocking immunotherapy response through novel biomarkers or combinatorial approaches
    Ünal Metin Tokat, Nalan Akgul Babacan, Mutlu Demiray
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  16. A CD68-expressing tissue-homing subset in peripheral CD8+ T cells predicts response to anti-PD-1 therapy in lung cancer
    Ying Wang, Jing Huang, Zhengyi Sun +2
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  17. TRIM14 recruits BRCC3 to stabilize PD-L1 by suppressing p62-dependent selective autophagy in glioma
    Yan Wu, Xujun Wang, Mengqiu Li +3
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefPMC
  18. FGFR pathway inhibition enhances PD-1 blockade and modulates antitumor immunity in colorectal cancer models.
    Zhou Shang, Changqing Jing, Jiyuan Liu +5
    BMC cancerPeer-reviewedCC BYFull textOncologyEurope PMC
  19. Clinical features associated with exceptional response on first-line anti-HER2-based therapy for metastatic breast cancer: real-world data from the ESME national cohort.
    Thomas Grinda, Matthieu Carton, Stefania Morganti +17
    Breast (Edinburgh, Scotland)Peer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  20. Transcriptomic profiling reveals autophagy-associated programs and prognostic biomarkers in anoikis-resistant pancreatic cancer cells.
    Lizhi Lin, Monika Bauden, Roland Andersson +1
    BMC cancerPeer-reviewedCC BYFull textOncologyEurope PMC
  21. Patient-derived gastric cancer organoids for functional precision oncology: disease-specific bottlenecks and clinical readiness.
    Chenyang Mi, Xuechao Liu, Xiaowen Tang +1
    Translational oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  22. Evidence for Dose Optimization of Immune Checkpoint Inhibitors.
    Sewanti Limaye, Vanita Noronha, Kumar Prabhash
    Journal of immunotherapy and precision oncologyPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  23. Comprehensive multi-omics analysis identifies BTG2 as a potential regulator of radiotherapy response in lung adenocarcinoma.
    Ming-Hao Wang, Xiao-Jing Wei, Yu Wang +6
    Neoplasia (New York, N.Y.)Peer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  24. JAK-STAT Signaling: Mechanisms and Therapeutics in Stem Cell Biology
    Willis X. Li
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMC
  25. Double-base deletions and signatures associated with platinum adducts in metastatic cancer
    Marcel Smid, Lotte van Leeuwen, Saskia M Wilting +1
    Nucleic Acids ResearchPeer-reviewedCC BY-NC 4.0Full textOncologyCrossref